Source: The Pharma Letter We already know that increasing numbers of patients are going online for medical advice. With the rise in mobile health applications and wearable technology, it’s no surprise that pharma companies are falling over themselves to launch mobile apps focussed on specific con...

Published on FierceBiotechIT (http://www.fiercebiotechit.com) Merck invests in an FDA-cleared mobile diabetes management business January 13, 2014 | By Nick Paul Taylor Since setting up shop in 2006, WellDoc has financed development of its mobile diabetes management tool through debt...

Can Pharma Build Apps for Long-Term Use? Posted on: October 28th, 2013 Today there are more than 100,000 health and fitness related mobile apps available in the world’s top app stores. According to the Pew Internet & American Life Project Mobile Health 2012 survey, one-fifth of smartphon...

3 ideas for pharma companies to become bigger players in mobile health August 9, 2013 5:16 pm by Deanna Pogorelc Despite its efforts, Big Pharma hasn’t exactly taken a big bite out of the mobile health market. According to a new report from mobile app research firmresearch2guidance, only one ph...

Seeking Patient Engagement, Payer Curates Mobile Apps Scott Mace, for HealthLeaders Media , July 9, 2013   Aetna is rounding out its mobile strategy by selecting more than 20 Web-based healthcare applications for its own CarePass wellness app, which pulls data from various sources and presents v...

By Kathlyn Stone, About.com Guide According to healthcare recruitment firm Jackson & Coker, almost 80 percent of U.S. physicians are using tablet PCs and smartphones in their daily work. Manhattan Research found that 62 percent of U.S. physicians are using tablets, primarily iPads. A survey ...

  PITTSBURGH, Sept. 6, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched the first ever app of its Generic Brand Reference® (GBR) Guide, a free reference and educational tool that helps U.S. health care professionals, patients and pharmacy students to quickly i...

App serves as a teaching tool and can provide guidance for treatment with Lilly Glucagon for Injection (rDNA origin) during severe hypoglycemic events [CHECK OUT THE APP NOW] INDIANAPOLIS, Sept. 4, 2012 /PRNewswire/ -- News Highlights Lilly Diabetes launches Lilly Glucagon Mobile App to su...

Written by Tom Lewis (iMedicalApps) Sepsis strikes approximately 750,000 people in the US and is responsible for more than 215,000 deaths. Mortality remains high at 25-50% at a cost of $17 billion each year. These figures suggest that control and recognition of sepsis is relatively poor and there ...